Blockade of the ERK or PI3K–Akt signaling pathway enhances the cytotoxicity of histone deacetylase inhibitors in tumor cells resistant to gefitinib or imatinib

✍ Scribed by Kei-ichi Ozaki; Masaki Kosugi; Nobuyuki Baba; Kohsuke Fujio; Toshiaki Sakamoto; Shinya Kimura; Susumu Tanimura; Michiaki Kohno

• Book ID: 116299653
• Publisher: Elsevier Science
• Year: 2010
• Tongue: English
• Weight: 748 KB
• Volume: 391
• Category: Article
• ISSN: 0006-291X
• DOI: 10.1016/j.bbrc.2009.12.086